NeuroAmino-SP (K-44)
NeuroAmino-SP (K-44) by Apex Energetics is an 'Other Combinations' nootropic supplement containing six ingredients aimed at cognitive support. Each vegetarian capsule provides 100mg of Alpha-GPC, which is considered a clinical dose for this compound. However, the formulation includes L-Tyrosine at 100mg, which is generally considered underdosed for cognitive benefits based on current research. The product received an N+ Score of 55, earning an 'F' grade, with ingredient adequacy and formula completeness both at 25%. Label transparency is excellent at 100%, clearly listing all ingredients and their dosages. This product may be considered by individuals interested in Alpha-GPC for cognitive support, but they should note the underdosed L-Tyrosine and the overall low N+ Score.
About This Product
NeuroAmino-SP (K-44) by Apex Energetics is a nootropics supplement containing 6 active ingredients. It has earned an N+ Score of 52/100 (Grade F).
Notable clinical-dose ingredients include Alpha-GPC.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +1 ingredient(s) at clinical dose levels
Weaknesses
- −Several ingredients below clinically effective doses
- −Missing several expected ingredients for its category
Ingredient Analysis (6 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| N-Acetyl L-Tyrosine | 100.000 mg | Under |
| L-Tryptophan | 40.000 mg | N/A |
| L-Tyrosine | 100.000 mg | Under |
| 5-HTP | 40.000 mg | N/A |
| Alpha-GPC | 100.000 mg | Adequate |
| L-Phenylalanine | 200.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.